AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliminyle-M 2mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Erinyle Pharma

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Gliminyle-M 2mg/1000mg Tablet

DiaBeta-Duo 2mg/1000mg tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Administer DiaBeta-Duo with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Maintain regular meals, and carry a rapid-acting glucose source (e.g., sweets, juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess hematological parameters and liver function.

Primary Ingredients of Gliminyle-M 2mg/1000mg Tablet

No text provided to rephrase.

Uses of Gliminyle-M 2mg/1000mg Tablet

Managing Type 2 Diabetes

Major Benefits of Gliminyle-M 2mg/1000mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2mg/1000mg Gliminyle-M tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.

Common Side effects of Gliminyle-M 2mg/1000mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliminyle-M 2mg/1000mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2mg/1000mg Gliminyle-M tablet whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.

How Gliminyle-M 2mg/1000mg Tablet works:

Each Gliminyle-M 2mg/1000mg tablet unites glimepiride (2mg) and metformin (1000mg), two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliminyle-M 2mg/1000mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliminyle-M 2mg/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Use of Gliminyle-M 2mg/1000mg tablets is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Gliminyle-M 2mg/1000mg tablets, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gliminyle-M 2mg/1000mg tablets. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliminyle-M 2mg/1000mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, a low initial dose is typically recommended, while use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Gliminyle-M 2mg/1000mg Tablet :

Should you forget to take a Gliminyle-M 2mg/1000mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliminyle-M 2mg/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliminyle-M 2mg/1000mg Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Gliminyle-M 2mg/1000mg Tablets can cause lactic acidosis, a serious medical emergency involving excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliminyle-M 2mg/1000mg Tablets and seek immediate medical attention.
Gliminyle-M 2mg/1000mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gliminyle-M 2mg/1000mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Gliminyle-M 2mg/1000mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake at least annually is recommended by some researchers.
Gliminyle-M 2mg/1000mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Gliminyle-M 2mg/1000mg tablets with alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Gliminyle-M 2mg/1000mg Ta...
68
MRP 83
18% off